- Home
- HMST vs CMPS Comparison
HMST vs CMPS Comparison
Compare HMST & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- CMPS
- Stock Information
- Founded
- HMST 1921
- CMPS 2020
- Country
- HMST United States
- CMPS United Kingdom
- Employees
- HMST N/A
- CMPS N/A
- Industry
- HMST Major Banks
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- HMST Finance
- CMPS Health Care
- Exchange
- HMST Nasdaq
- CMPS Nasdaq
- Market Cap
- HMST 287.6M
- CMPS 280.2M
- IPO Year
- HMST 2012
- CMPS 2020
- Fundamental
- Price
- HMST $11.35
- CMPS $4.22
- Analyst Decision
- HMST Buy
- CMPS Strong Buy
- Analyst Count
- HMST 2
- CMPS 6
- Target Price
- HMST $13.25
- CMPS $33.60
- AVG Volume (30 Days)
- HMST 159.1K
- CMPS 841.8K
- Earning Date
- HMST 01-27-2025
- CMPS 10-31-2024
- Dividend Yield
- HMST N/A
- CMPS N/A
- EPS Growth
- HMST N/A
- CMPS N/A
- EPS
- HMST N/A
- CMPS N/A
- Revenue
- HMST $169,710,000.00
- CMPS N/A
- Revenue This Year
- HMST N/A
- CMPS N/A
- Revenue Next Year
- HMST $12.08
- CMPS N/A
- P/E Ratio
- HMST N/A
- CMPS N/A
- Revenue Growth
- HMST N/A
- CMPS N/A
- 52 Week Low
- HMST $8.09
- CMPS $4.00
- 52 Week High
- HMST $16.10
- CMPS $12.75
- Technical
- Relative Strength Index (RSI)
- HMST 42.80
- CMPS 37.99
- Support Level
- HMST $11.46
- CMPS $4.00
- Resistance Level
- HMST $11.72
- CMPS $4.91
- Average True Range (ATR)
- HMST 0.37
- CMPS 0.26
- MACD
- HMST 0.05
- CMPS 0.04
- Stochastic Oscillator
- HMST 13.51
- CMPS 24.18
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.